References
- Spergel, J.M., Paller, A.S. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 112(6 Suppl):S118-127, 2003. https://doi.org/10.1016/j.jaci.2003.09.033
- Leung, D.Y., Bieber, T. Atopic dermatitis. Lancet. 361(9352): 151-160, 2003. https://doi.org/10.1016/S0140-6736(03)12193-9
- Leung, D.Y., Boguniewicz, M., Howell, M.D., Nomura, I., Hamid, Q.A. New insights into atopic dermatitis. J Clin Invest. 113: 651-657, 2004. https://doi.org/10.1172/JCI21060
- Mohrenschlager, M., Darsow, U., Schnopp, C., Ring, J. Atopic eczema: what's new? J Eur Acad Dermatol Venereol. 20: 503-513, 2006. https://doi.org/10.1111/j.1468-3083.2006.01580.x
- Novak, N., Bieber, T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol. 112: 252-262, 2003. https://doi.org/10.1067/mai.2003.1595
- Schultz-Larsen, F., Hanifin, J.M. Epidermiology of atopic dermatitis. Immunol Allergy Clin North Am. 22: 1-24, 2002. https://doi.org/10.1016/S0889-8561(03)00066-3
- Rollins, B.J., Yoshimura, T., Leonard, E.J., Pober, J.S. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol. 136: 1229-1233, 1990.
- Power, C.A., Proudfoot, A.E. The chemokine system: novel broad-spectrum therapeutic targets. Curr Opin Pharmacol. 1: 417-424, 2001. https://doi.org/10.1016/S1471-4892(01)00072-8
- Pivarcsi, A., Homey, B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep. 5: 284-290, 2005. https://doi.org/10.1007/s11882-005-0068-y
- Reiss, Y., Proudfoot, A.E., Power, C.A., Campbell, J.J., Butcher, E.C. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med. 194: 1541-1547, 2001. https://doi.org/10.1084/jem.194.10.1541
- Nakazato, J., Kishida, M., Kuroiwa, R., Fujiwara, J., Shimoda, M., Shinomiya, N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol. 19: 605-613, 2008.
- 정승일, 최병민, 윤용갑, 이장원, 장선일. 천연물 유래 Th2 케모카인 억제제 발굴에 의한 새로운 아토피 피부염 치료기술 개발 : 아토피 피부염 모델 NC/Nga 마우스에서 고삼 추출액의 억제 효과. 대한한의학방제학회지 17: 141-151, 2009.
- Gao, X.K., Fuseda, K., Shibata, T., Tanaka, H., Inagaki, N., Nagai, H. Kampo Medicines for Mite Antigen-Induced Allergic Dermatitis in NC/Nga Mice. Evid Based Complement Alternat Med. 2: 191-199, 2005. https://doi.org/10.1093/ecam/neh077
- Park, E.K., Rhee, H.I., Jung, H.S., Ju, S.M., Lee, Y.A., Lee, S.H., Hong, S.J., Yang, H.I., Yoo, M.C., Kim, K.S. Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation. Phytother Res. 21: 746-750, 2007. https://doi.org/10.1002/ptr.2156
- Noh, S.U., Cho, E.A., Kim, H.O., Park, Y.M. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor. Int Immunopharmacol. 28: 1172-1182, 2008.
-
Jang, S.I. Wogonin inhibits Cytokine-induced TARC/CCL17 Expression by Suppression of NF-
$\kappa$ B activation via p38 MAP kinase Signalning Pathways in HaCaT Keratinocytes. Korean J. Oriental Physiol. Pathol. 21: 1017-1024, 2007. - Yun, Y.G., Kim, G.M., Lee, S.J., Ryu, S.H., Jang, S.I. JangInhibitory Effect of Aqueous Extract from Lonicera japonica Flower on LPS-induced Inflammatory Mediators in RAW 264.7 Macrophages. Korean J. Herbol. 22: 117-125, 2007.
-
Choi, B.M., Jeong, S.I., Mok, J.Y., Jang, S.I. Sulforaphane suppresses IFN-γ and TNF-
$\alpha$ -stimulated TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF$\kappa$ B in HaCaT keratinocytes. J. Dermatol. 2010 (in press). - Higa, T., Ke, B. Clinical and basic medical research on EMX. EMRO Okinawa, 2001.
- Chui, C.H., Cheng, G.Y., Ke, B., Lau, F.Y., Wong, R.S., Kok, S.H., Fatima, S., Cheung, F., Cheng, C.H., Chan, A.S., Tang, J.C. Growth inhibitory potential of effective microorganism fermentation extract (EM-X) on cancer cells. Int J Mol Med. 14: 925-929, 2004.
- Aruoma, O.I., Deiana, M., Rosa, A., Casu, V., Piga, R., Peccagnini, S., Dessi, M.A., Ke, B., Liang, Y.F., Higa, T. Assessment of the ability of the antioxidant cocktail-derived from fermentation of plants with effective microorganisms (EM-X) to modulate oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of poly- and mono-unsaturated fatty acids. Toxicol Lett 135: 209-217, 2002. https://doi.org/10.1016/S0378-4274(02)00261-8
- Deiana, M., Dessi, M.A., Ke, B., Liang, Y.F., Higa, T., Gilmour, P.S., Jen, L.S., Rahman, I., Aruoma, O.I. The antioxidant cocktail effective microorganism X (EM-X) inhibits oxidant-induced interleukin-8 release and the peroxidation of phospholipids in vitro. Biochem Biophys Res Commun 296: 1148-1151, 2002. https://doi.org/10.1016/S0006-291X(02)02061-2
- Aruoma, O.I., Moncaster, J.A., Walsh, D.T., Gentleman, S.M., Ke, B., Liang, Y.F., Higa, T., Jen, L.S. The antioxidant cocktail, effective microorganism X (EM-X), protects retinal neurons in rats against N-methyl-D-aspartate excitotoxicity in vivo. Free Radic Res 37: 91-97, 2003. https://doi.org/10.1080/1071576021000036605
- Datla, K.P., Bennett, R.D., Zbarsky, V., Ke, B., Liang, Y.F., Higa, T., Bahorun, T., Aruoma, O.I., Dexter, D.T. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. J Pharm Pharmacol 56: 649-654, 2004. https://doi.org/10.1211/0022357023222
- Do, J.S., Seo, H.J., Hwang, J.K., Kim, J.H., Nam, S.Y. Effective microorganism fermentation extract (EM-X) attenuates airway hyperreactivity and inflammation through selective inhibition of the TH2 response independently of antioxidant activity. Int J Mol Med. 220: 631-635, 2007.
- Hanifin, J.M., Cooper, K.D., Ho, V.C., Kang, S., Krafchik, B.R., Margolis, D.J., Schachner, L.A., Sidbury, R., Whitmore, S.E., Sieck, C.K., Van Voorhees, A.S. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol. 50: 391-404, 2004. https://doi.org/10.1016/j.jaad.2003.08.003
- Matsuda, H., Watanabe, N., Geba, G.P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P.W., Ra, C. Development of atopic dermatitis-like skin lesion with IgE-hyperproduction in NC/Nga mice. Int Immunol. 9: 461-466, 1997. https://doi.org/10.1093/intimm/9.3.461
- Yamamoto, M., Haruna, T., Yasui, K., Takahashi, H., Iduhara, M., Takaki, S., Deguchi, M., Arimura, A. A Novel Atopic Dermatitis Model Induced by Topical Application with Dermatophagoides Farinae Extract in NC/Nga Mice. Allergol Int. 56: 139-148, 2007. https://doi.org/10.2332/allergolint.O-06-458
- Tsunemi, Y., Saeki, H., Nakamura, K., Nagakubo, D., Nakayama, T., Yoshie, O., Kagami, S., Shimazu, K., Kadono, T., Sugaya, M., Komine, M., Matsushima, K., Tamaki, K. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol. 36: 2116-2127, 2006. https://doi.org/10.1002/eji.200535564
- Sebastiani, S., Danelon, G., Gerber, B., Uguccioni, M. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine. Eur J Immunol. 35: 746-756, 2005. https://doi.org/10.1002/eji.200525800
- Reiss, Y., Proudfoot, A.E., Power, C.A., Campbell, J.J., Butcher, E.C. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med. 194: 1541-1547, 2001. https://doi.org/10.1084/jem.194.10.1541
- Homey, B., Alenius, H., Müller, A., Soto, H., Bowman, E.P,, Yuan, W., McEvoy, L., Lauerma, A.I., Assmann, T., Bünemann, E., Lehto, M., Wolff, H., Yen, D., Marxhausen, H., To, W., Sedgwick, J., Ruzicka, T., Lehmann, P., Zlotnik, A. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med. 8: 157-165, 2002. https://doi.org/10.1038/nm0202-157
- Oshio, T., Sasaki, Y., Funakoshi-Tago, M., Aizu-Yokota, E., Sonoda, Y., Matsuoka, H., Kasahara, T. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment. Int Immunopharmacol. 9: 403-411, 2009. https://doi.org/10.1016/j.intimp.2008.12.013
- Nakazato, J., Kishida, M., Kuroiwa, R., Fujiwara, J., Shimoda, M., Shinomiya, N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol. 19: 605-613, 2008.
- Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K.,, Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H., Matsushima, K. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest. 104: 1097-1105, 1999. https://doi.org/10.1172/JCI7613